0001666071-24-000017.txt : 20240103
0001666071-24-000017.hdr.sgml : 20240103
20240103195950
ACCESSION NUMBER: 0001666071-24-000017
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240101
FILED AS OF DATE: 20240103
DATE AS OF CHANGE: 20240103
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Lynton Nicholas Hollmeyer
CENTRAL INDEX KEY: 0001941467
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38386
FILM NUMBER: 24509311
MAIL ADDRESS:
STREET 1: C/O CARDLYTICS, INC.
STREET 2: 675 PONCE DE LEON AVENUE NE, SUITE 6000
CITY: ATLANTA
STATE: GA
ZIP: 30308
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Cardlytics, Inc.
CENTRAL INDEX KEY: 0001666071
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-COMPUTER PROGRAMMING, DATA PROCESSING, ETC. [7370]
ORGANIZATION NAME: 06 Technology
IRS NUMBER: 263039436
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 675 PONCE DE LEON AVENUE, NE
STREET 2: SUITE 4100
CITY: ATLANTA
STATE: GA
ZIP: 30308
BUSINESS PHONE: 888-798-5802
MAIL ADDRESS:
STREET 1: 675 PONCE DE LEON AVENUE, NE
STREET 2: SUITE 4100
CITY: ATLANTA
STATE: GA
ZIP: 30308
4
1
wk-form4_1704329973.xml
FORM 4
X0508
4
2024-01-01
0
0001666071
Cardlytics, Inc.
CDLX
0001941467
Lynton Nicholas Hollmeyer
675 PONCE DE LEON AVENUE NE
SUITE 4100
ATLANTA
GA
30308
0
1
0
0
Chief Legal & Privacy Officer
0
Common Stock
2024-01-01
4
M
0
25000
A
69310
D
Common Stock
2024-01-01
4
M
0
1578
A
70888
D
Common Stock
2024-01-01
4
M
0
581
A
71469
D
Common Stock
2024-01-03
4
S
0
15620
7.77
D
55849
D
Restricted Stock Unit
2024-01-01
4
M
0
25000
0
D
Common Stock
25000
25000
D
Restricted Stock Unit
2024-01-01
4
M
0
1578
0
D
Common Stock
1578
15780
D
Restricted Stock Unit
2024-01-01
4
M
0
581
0
D
Common Stock
581
5231
D
Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock of the Issuer.
Shares sold to satisfy withholding tax obligations upon the delivery of shares of common stock for RSUs that vested on January 1, 2024.
The price reported is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $7.50 to $8.3825, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (3).
This RSU award was originally for 100,000 shares. 25% of the RSUs award vested on each of July 1, 2023, October 1, 2023 and January 1, 2024. An additional 25% of the RSU award shall vest on April 1, 2024, subject to the Reporting Person's continuous service with the Issuer through the vesting date.
This RSU award was originally for 38,222 shares. Twenty-five percent (25%) of the shares under this award vested on July 1, 2023, with the remaining 75% vesting quarterly over the subsequent three years in equal amounts thereafter provided the Reporting Person continuously provides service to the Issuer through the vesting date.
The RSU award was originally for 9,299 shares. Twenty-five percent (25%) of the shares under this award vested on April 1, 2023, with the remaining 75% vesting quarterly over the subsequent three years in equal amounts thereafter provided the Reporting Person continuously provides service to the Issuer through the vesting date.
/s/ Nick Lynton, Attorney-in-Fact
2024-01-03